Titre : Sclérodermie diffuse

Sclérodermie diffuse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Accuracy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sclérodermie diffuse : Questions médicales les plus fréquentes", "headline": "Sclérodermie diffuse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sclérodermie diffuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-29", "dateModified": "2025-02-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sclérodermie diffuse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sclérodermie systémique", "url": "https://questionsmedicales.fr/mesh/D012595", "about": { "@type": "MedicalCondition", "name": "Sclérodermie systémique", "code": { "@type": "MedicalCode", "code": "D012595", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.800.784" } } }, "about": { "@type": "MedicalCondition", "name": "Sclérodermie diffuse", "alternateName": "Scleroderma, Diffuse", "code": { "@type": "MedicalCode", "code": "D045743", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Dinesh Khanna", "url": "https://questionsmedicales.fr/author/Dinesh%20Khanna", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA." } }, { "@type": "Person", "name": "Christopher P Denton", "url": "https://questionsmedicales.fr/author/Christopher%20P%20Denton", "affiliation": { "@type": "Organization", "name": "UCL Division of Medicine, Royal Free Campus, London, UK." } }, { "@type": "Person", "name": "Ami A Shah", "url": "https://questionsmedicales.fr/author/Ami%20A%20Shah", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Suite 4100, Baltimore, MD 21224, USA. Electronic address: Ami.Shah@jhmi.edu." } }, { "@type": "Person", "name": "Susanna Proudman", "url": "https://questionsmedicales.fr/author/Susanna%20Proudman", "affiliation": { "@type": "Organization", "name": "Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Initiatives, Concepts, and Implementation Practices of the Findable, Accessible, Interoperable, and Reusable Data Principles in Health Data Stewardship: Scoping Review.", "datePublished": "2023-08-28", "url": "https://questionsmedicales.fr/article/37639292", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/45013" } }, { "@type": "ScholarlyArticle", "name": "Equity and bias in electronic health records data.", "datePublished": "2023-05-22", "url": "https://questionsmedicales.fr/article/37225122", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cct.2023.107238" } }, { "@type": "ScholarlyArticle", "name": "Data quality and autism: Issues and potential impacts.", "datePublished": "2022-11-28", "url": "https://questionsmedicales.fr/article/36455477", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijmedinf.2022.104938" } }, { "@type": "ScholarlyArticle", "name": "The Detection of Date Shifting in Real-World Data.", "datePublished": "2023-07-17", "url": "https://questionsmedicales.fr/article/37459888", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2130-2197" } }, { "@type": "ScholarlyArticle", "name": "Tailoring Rule-Based Data Quality Assessment to the Patient-Centered Outcomes Research Network (PCORnet) Common Data Model (CDM).", "datePublished": "2023-04-29", "url": "https://questionsmedicales.fr/article/37128433", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": null } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de la peau et du tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D017437" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la peau", "item": "https://questionsmedicales.fr/mesh/D012871" }, { "@type": "ListItem", "position": 4, "name": "Sclérodermie systémique", "item": "https://questionsmedicales.fr/mesh/D012595" }, { "@type": "ListItem", "position": 5, "name": "Sclérodermie diffuse", "item": "https://questionsmedicales.fr/mesh/D045743" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sclérodermie diffuse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sclérodermie diffuse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sclérodermie diffuse", "description": "Comment diagnostiquer la sclérodermie diffuse ?\nQuels tests sanguins sont utilisés ?\nLes biopsies cutanées sont-elles nécessaires ?\nQuels signes cliniques sont observés ?\nLa radiographie est-elle utile dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Data+Accuracy&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sclérodermie diffuse", "description": "Quels sont les symptômes principaux ?\nLa fatigue est-elle un symptôme courant ?\nY a-t-il des symptômes respiratoires ?\nComment se manifeste l'atteinte digestive ?\nLes troubles vasculaires sont-ils fréquents ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Data+Accuracy&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sclérodermie diffuse", "description": "Peut-on prévenir la sclérodermie diffuse ?\nQuels facteurs de risque sont identifiés ?\nLe tabagisme influence-t-il la maladie ?\nL'exposition au froid est-elle un risque ?\nLes infections peuvent-elles aggraver la maladie ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Data+Accuracy&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sclérodermie diffuse", "description": "Quels traitements sont disponibles ?\nLes corticostéroïdes sont-ils efficaces ?\nQuelles thérapies physiques sont recommandées ?\nY a-t-il des traitements expérimentaux ?\nComment gérer les symptômes cutanés ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Data+Accuracy&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sclérodermie diffuse", "description": "Quelles sont les complications possibles ?\nLa sclérodermie peut-elle affecter le cœur ?\nY a-t-il un risque d'infections ?\nComment la sclérodermie affecte-t-elle les reins ?\nLes complications digestives sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Data+Accuracy&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sclérodermie diffuse", "description": "Quels sont les principaux facteurs de risque ?\nL'âge joue-t-il un rôle ?\nLes facteurs environnementaux sont-ils significatifs ?\nY a-t-il un lien avec d'autres maladies auto-immunes ?\nLe stress peut-il aggraver la maladie ?", "url": "https://questionsmedicales.fr/mesh/D045743?mesh_terms=Data+Accuracy&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la sclérodermie diffuse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique, les antécédents médicaux et des tests sanguins." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la recherche d'anticorps spécifiques comme les anticorps anti-Scl-70." } }, { "@type": "Question", "name": "Les biopsies cutanées sont-elles nécessaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être réalisées pour évaluer l'atteinte tissulaire et confirmer le diagnostic." } }, { "@type": "Question", "name": "Quels signes cliniques sont observés ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent un durcissement de la peau, des œdèmes et des troubles vasculaires." } }, { "@type": "Question", "name": "La radiographie est-elle utile dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aider à évaluer les atteintes pulmonaires ou digestives associées." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent un durcissement de la peau, des douleurs articulaires et des troubles digestifs." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme courant ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue est fréquente et peut être liée à l'inflammation et à l'atteinte organique." } }, { "@type": "Question", "name": "Y a-t-il des symptômes respiratoires ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des difficultés respiratoires peuvent survenir en raison de l'atteinte pulmonaire." } }, { "@type": "Question", "name": "Comment se manifeste l'atteinte digestive ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se traduire par des reflux, des troubles de la déglutition et des douleurs abdominales." } }, { "@type": "Question", "name": "Les troubles vasculaires sont-ils fréquents ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des phénomènes de Raynaud et des ulcères digitaux peuvent se produire." } }, { "@type": "Question", "name": "Peut-on prévenir la sclérodermie diffuse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention connue, mais éviter les facteurs de risque peut aider." } }, { "@type": "Question", "name": "Quels facteurs de risque sont identifiés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des expositions environnementales et le sexe féminin." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la maladie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut aggraver les symptômes et augmenter le risque de complications." } }, { "@type": "Question", "name": "L'exposition au froid est-elle un risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition au froid peut déclencher des symptômes vasculaires comme le phénomène de Raynaud." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver la maladie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent exacerber les symptômes et compliquer la gestion de la maladie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des immunosuppresseurs, des anti-inflammatoires et des thérapies symptomatiques." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent réduire l'inflammation, mais leur utilisation doit être prudente en raison des effets secondaires." } }, { "@type": "Question", "name": "Quelles thérapies physiques sont recommandées ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La kinésithérapie peut aider à maintenir la mobilité et à réduire la douleur articulaire." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements comme les inhibiteurs de la tyrosine kinase sont en cours d'évaluation." } }, { "@type": "Question", "name": "Comment gérer les symptômes cutanés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des crèmes hydratantes et des traitements topiques peuvent aider à soulager les symptômes cutanés." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des atteintes pulmonaires, cardiaques et rénales, ainsi que des troubles digestifs." } }, { "@type": "Question", "name": "La sclérodermie peut-elle affecter le cœur ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des arythmies, une hypertension pulmonaire et une insuffisance cardiaque." } }, { "@type": "Question", "name": "Y a-t-il un risque d'infections ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent être plus susceptibles aux infections en raison d'une immunité altérée." } }, { "@type": "Question", "name": "Comment la sclérodermie affecte-t-elle les reins ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une hypertension rénale et une insuffisance rénale, nécessitant une surveillance." } }, { "@type": "Question", "name": "Les complications digestives sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des reflux, des troubles de la motilité et des malabsorption." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, le sexe féminin et certaines expositions environnementales sont des facteurs de risque." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la sclérodermie diffuse survient généralement entre 30 et 50 ans, mais peut toucher d'autres âges." } }, { "@type": "Question", "name": "Les facteurs environnementaux sont-ils significatifs ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des solvants organiques et à la silice peut augmenter le risque." } }, { "@type": "Question", "name": "Y a-t-il un lien avec d'autres maladies auto-immunes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant d'autres maladies auto-immunes peuvent avoir un risque accru." } }, { "@type": "Question", "name": "Le stress peut-il aggraver la maladie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut exacerber les symptômes, bien que son rôle exact dans la sclérodermie ne soit pas clair." } } ] } ] }

Sources (10000 au total)

Initiatives, Concepts, and Implementation Practices of the Findable, Accessible, Interoperable, and Reusable Data Principles in Health Data Stewardship: Scoping Review.

Thorough data stewardship is a key enabler of comprehensive health research. Processes such as data collection, storage, access, sharing, and analytics require researchers to follow elaborate data man... This scoping review identifies and discusses concepts, approaches, implementation experiences, and lessons learned in FAIR initiatives in health research data.... The Arksey and O'Malley stage-based methodological framework for scoping reviews was applied. PubMed, Web of Science, and Google Scholar were searched to access relevant publications. Articles written... A total of 2.18% (34/1561) of the screened articles were included in the final review. The authors reported FAIRification approaches, which include interpolation, inclusion of comprehensive data dicti... This work summarises projects, tools, and workflows for the FAIRification of health research data. The comprehensive review shows that implementing the FAIR concept in health data stewardship carries ... RR2-10.2196/22505....

Data quality and autism: Issues and potential impacts.

Large healthcare datasets can provide insight that has the potential to improve outcomes for patients. However, it is important to understand the strengths and limitations of such datasets so that the... Data were extracted from the HES database for the period 1st April 2013 to 31st March 2021 for patients with a diagnosis of autism. First spells in hospital during the study period were identified for... Data were available for 172,324 unique patients who had been recorded as having an autism diagnosis on first admission. In total, 43.7 % of subsequent spells were found to have inconsistencies. The fe... Data inconsistencies in the HES database were relatively common in autistic patients and were associated a number of patient and hospital admission characteristics. Such inconsistencies have the poten...

The Detection of Date Shifting in Real-World Data.

Analysis of health care real-world data (RWD) provides an opportunity to observe the actual patient diagnostic, treatment, and outcome events. However, researchers should understand the possible limit... A methodology for detecting the presence of shifted dates in RWD was developed by considering various approaches to confirm the expected occurrences of medical events, including unique temporal occurr... Twenty-eight of the 71 HCOs analyzed were predicted by methodology and confirmed by their data providers to have shifted data. Likewise, 39 were predicted and confirmed to not have shifted data. With ... The presence of date shifting for U.S. HCOs may be reliably detected assessing whether the routine exams should always occur on weekdays....

Assessing the quality of emergency department data for injury surveillance in Victoria, Australia: a comparative analysis of two Victorian hospital data sources.

The emergency department (ED) is pivotal in treating serious injuries, making it a valuable source for population-based injury surveillance. In Victoria, information that is relevant to injury surveil... A retrospective observational study of administrative healthcare data.... VEMD and VAED data from July 2014 to June 2019 were compared. Including only hospitals contributing to both datasets, cases that (1) arrived at the ED and (2) were subsequently admitted, were selected... While the overall number of cases was similar, VAED outnumbered VEMD cases (414 630 vs 404 608), suggesting potential under-reporting of injuries in the ED. Age-related differences indicated a relativ... Injury cases were more numerous in the VAED than in the VEMD even though the number is expected to be equal based on case selection. Older patients were under-represented in the VEMD; this could partl...

Improving the Data Quality of Untargeted Metabolomics through a Targeted Data-Dependent Acquisition Based on an Inclusion List of Differential and Preidentified Ions.

Metabolomics based on high-resolution mass spectrometry has become a powerful technique in biomedical research. The development of various analytical tools and online libraries has promoted the identi...

Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections.

As a national effort to better understand the current pandemic, three cohorts collect sociodemographic and clinical data from coronavirus disease 2019 (COVID-19) patients from different target populat... The goal of this work is to assure high consistency of research data mapped to the GECCO data model. In particular, it aims at identifying contradictions within interdependent GECCO data items of the ... All suitable data items from each of the three NAPKON cohorts are mapped to the GECCO items. A consistency assessment tool (dqGecco) is implemented, following the design of an existing quality assessm... Our consistency assessment tool helped in correcting the mapping procedure and reveals remaining contradictory value combinations within COVID-19 symptoms, vital signs, and COVID-19 severity. Consiste... An efficient and portable tool capable of discovering inconsistencies in the COVID-19 domain has been developed and applied to three different cohorts. As the GECCO dataset is employed in different pl...

Routine use of DHIS2 data: a scoping review.

In regard to health service planning and delivery, the use of information at different levels in the health system is vital, ranging from the influencing of policy to the programming of action to the ... The five-stage approach of Arksey and O'Malley progressed by Levac et al. and Peters was followed. Three databases (PubMed, Web of Science and Embase) were searched, along with relevant conference pro... Overall, DHIS2 data are being used but there are few detailed descriptions of this usage in peer reviewed or grey literature. We find that, commonly, there exists a centralised versus decentralised pa... We conclude with some suggestions for a way forward, namely: i) the need to document in more detail and share how data are being used, ii) the need to investigate how data were created and who uses su...

"We don't trust all data coming from all facilities": factors influencing the quality of care network data quality in Ethiopia.

Good quality data are a key to quality health care. In 2017, WHO has launched the Quality of Care Network (QCN) to reduce maternal, newborn and stillbirth mortality via learning and sharing networks. ... This paper seeks to explore how QCN has contributed to improving data quality and to identify factors influencing quality of data in Ethiopia.... We conducted a qualitative study in selected QCN facilities in Ethiopia using key informant interview and observation methods. We interviewed 40 people at national, sub-national and facility levels. N... There was a general perception that QCN had improved health data documentation and use in the learning facilities, achieved through coaching, learning and building from pre-existing initiatives. QCN a... There is evidence of QCN's contribution to improving data awareness. But a lack of inclusive engagement of actors, alignment and limited skill for data collection and analysis continued to affect data...